Distinct combinations of amino acid substitutions in N-terminal domain of Gag-capsid afford HIV-1 resistance to rhesus TRIM5α

Microbes and Infection

Volumn 16, Issue 11, 2014, Pages 936-944

  Nomaguchi, Masako ^a   Nakayama, Emi E ^b   Yokoyama, Masaru ^c   Doi, Naoya ^a,d   Igarashi, Tatsuhiko ^e   Shioda, Tatsuo ^b   Sato, Hironori ^c   Adachi, Akio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d The Japan Foundation   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

Capsid; Gag CA; HIV 1; HIV 1mt; Rhesus macaque; TRIM5

Indexed keywords

TRIPARTITE MOTIF PROTEIN 5; CAPSID PROTEIN; GAG PROTEIN; MUTANT PROTEIN; PROTEIN; TRIM5(ALPHA) PROTEIN, RHESUS MONKEY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL CHEMISTRY; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; VIROGENESIS; VIRUS CAPSID; VIRUS MUTATION; VIRUS REPLICATION; VIRUS RESISTANCE; ANIMAL; CELL LINE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RHESUS MONKEY; VIRAL TROPISM;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; MIRIDAE;

AMINO ACID SUBSTITUTION; ANIMALS; CAPSID PROTEINS; CELL LINE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; MACACA MULATTA; MUTANT PROTEINS; PROTEINS; VIRAL TROPISM; VIRUS REPLICATION;

EID: 84919469077     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.08.017     Document Type: Article

References (38)

1. Kratovac Z., Virgen C.A., Bibollet-Ruche F., Hahn B.H., Bieniasz P.D., Hatziioannou T. Primate lentivirus capsid sensitivity to TRIM5 proteins. J Virol 2008, 82:6772-6777.
2. Perron M.J., Stremlau M., Song B., Ulm W., Mulligan R.C., Sodroski J. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A 2004, 101:11827-11832.
3. Song B., Javanbakht H., Perron M., Park D.H., Stremlau M., Sodroski J. Retrovirus restriction by TRIM5alpha variants from old world and new world primates. J Virol 2005, 79:3930-3937.
4. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old world monkeys. Nature 2004, 427:848-853.
5. Yap M.W., Nisole S., Lynch C., Stoye J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 2004, 101:10786-10791.
6. Ylinen L.M., Keckesova Z., Wilson S.J., Ranasinghe S., Towers G.J. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J Virol 2005, 79:11580-11587.
7. Biris N., Tomashevski A., Bhattacharya A., Diaz-Griffero F., Ivanov D.N. Rhesus monkey TRIM5α SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the HIV-1 mature viral core. J Mol Biol 2013, 425:5032-5044.
8. Biris N., Yang Y., Taylor A.B., Tomashevski A., Guo M., Hart P.J., et al. Structure of the rhesus monkey TRIM5α PRYSPRY domain, the HIV capsid recognition module. Proc Natl Acad Sci U S A 2012, 109:13278-13283.
9. Ganser-Pornillos B.K., Chandrasekaran V., Pornillos O., Sodroski J.G., Sundquist W.I., Yeager M. Hexagonal assembly of a restricting TRIM5α protein. Proc Natl Acad Sci U S A 2011, 108:534-539.
10. Sebastian S., Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005, 2:40.
11. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 2006, 103:5514-5519.
12. Yang H., Ji X., Zhao G., Ning J., Zhao Q., Aiken C., et al. Structural insight into HIV-1 capsid recognition by rhesus TRIM5α. Proc Natl Acad Sci U S A 2012, 109:18372-18377.
13. Hatziioannou T., Evans D.T. Animal models for HIV/AIDS research. Nat Rev Microbiol 2012, 10:852-867.
14. Nomaguchi M., Doi N., Fujiwara S., Adachi A. Macaque-tropic HIV-1 derivatives: a novel experimental approach to understand viral replication and evolution invivo. HIV-host interactions 2011, 325-348. InTech, Rijeka, Croatia. http://www.intechopen.com/books/hiv-host-interactions/macaque-tropic-hiv-1-%20derivatives-a-novel-experimental-approach-to-understand-viral-replication-and-e, T.L.Y. Chang (Ed.).
15. Nomaguchi M., Yokoyama M., Kono K., Nakayama E.E., Shioda T., Doi N., et al. Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors. J Virol 2013, 87:11447-11461.
16. Soll S.J., Wilson S.J., Kutluay S.B., Hatziioannou T., Bieniasz P.D. Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism. PLoS Pathog 2013, 9:e1003667.
17. Hatziioannou T., Princiotta M., Piatak M., Yuan F., Zhang F., Lifson J.D., et al. Generation of simian-tropic HIV-1 by restriction factor evasion. Science 2006, 314:95.
18. Kono K., Song H., Yokoyama M., Sato H., Shioda T., Nakayama E.E. Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction. Retrovirology 2010, 7:72.
19. O'Doherty U., Swiggard W.J., Malim M.H. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 2004, 74:10074-10080.
20. Bichel K., Price A.J., Schaller T., Towers G.J., Freund S.M., James L.C. HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358. Retrovirology 2013, 10:81.
21. Hatziioannou T., Cowan S., Von Schwedler U.K., Sundquist W.I., Bieniasz P.D. Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol 2004, 78:6005-6012.
22. Kamada K., Igarashi T., Martin M.A., Khamsri B., Hatcho K., Yamashita T., et al. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc Natl Acad Sci U S A 2006, 103:16959-16964.
23. Kuroishi A., Saito A., Shingai Y., Shioda T., Nomaguchi M., Adachi A., et al. Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells. Retrovirology 2009, 6:70.
24. Lin T.Y., Emerman M. Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1. Virology 2008, 379:335-341.
25. McCarthy K.R., Schmidt A.G., Kirmaier A., Wyand A.L., Newman R.M., Johnson W.E. Gain-of-sensitivity mutations in a Trim5-resistant primary isolate of pathogenic SIV identify two independent conserved determinants of Trim5α specificity. PLoS Pathog 2013, 9:e1003352.
26. Nomaguchi M., Yokoyama M., Kono K., Nakayama E.E., Shioda T., Saito A., et al. Gag-CA Q110D mutation elicits TRIM5-independent enhancement of HIV-1mt replication in macaque cells. Microbes Infect 2013, 15:56-65.
27. Ohkura S., Goldstone D.C., Yap M.W., Holden-Dye K., Taylor I.A., Stoye J.P. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog 2011, 7:e1002011.
28. Owens C.M., Song B., Perron M.J., Yang P.C., Stremlau M., Sodroski J. Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J Virol 2004, 78:5423-5437.
29. Pacheco B., Finzi A., Stremlau M., Sodroski J. Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5α. Virology 2010, 408:204-212.
30. Kirmaier A., Wu F., Newman R.M., Hall L.R., Morgan J.S., O'Connor S., et al. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol 2010, 8:e1000462.
31. Newman R.M., Hall L., Connole M., Chen G.L., Sato S., Yuste E., et al. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha. Proc Natl Acad Sci U S A 2006, 103:19134-19139.
32. Wilson S.J., Webb B.L., Ylinen L.M., Verschoor E., Heeney J.L., Towers G.J. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc Natl Acad Sci U S A 2008, 105:3557-3562.
33. Price A.J., Marzetta F., Lammers M., Ylinen L.M., Schaller T., Wilson S.J., et al. Active site remodeling switches HIV specificity of antiretroviral TRIMCyp. Nat Struct Mol Biol 2009, 16:1036-1042.
34. Ylinen L.M., Price A.J., Rasaiyaah J., Hué S., Rose N.J., Marzetta F., et al. Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity. PLoS Pathog 2010, 6:e1001062.
35. Wu F., Kirmaier A., Goeken R., Ourmanov I., Hall L., Morgan J.S., et al. TRIM5 alpha drives SIVsmm evolution in rhesus macaques. PLoS Pathog 2013, 9:e1003577.
36. Doi N., Fujiwara S., Adachi A., Nomaguchi M. Rhesus M1.3S cells suitable for biological evaluation of macaque-tropic HIV/SIV clones. Front Microbiol 2011, 2:115.
37. von Schwedler U.K., Stray K.M., Garrus J.E., Sundquist W.I. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol 2003, 77:5439-5450.
38. Nomaguchi M., Doi N., Fujiwara S., Saito A., Akari H., Nakayama E.E., et al. Systemic biological analysis of the mutations in two distinct HIV-1mt genomes occurred during replication in macaque cells. Microbes Infect 2013, 15:319-328.